FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W308721738> ?p ?o ?g. }

• W308721738 endingPage "5" @default.
• W308721738 startingPage "751" @default.
• W308721738 abstract "To observe the peripheral neurotoxicity of 1-bromopropane (1-BP) by developing an animal model of peripheral neuropathy through oral administration of 1-BP.Forty male Wistar rats were randomly and equally divided into low-dose group (200 mg/kg), medium-dose group (400 mg/kg), high-dose group (800 mg/kg), and control group. The rats in the low-dose, medium-dose, and high-dose groups were orally given 1-BP (dissolved in corn oil), while the rats in the control group were orally given an equal volume of corn oil. The oral administration (0.2 ml/100 g BW) was performed once per day, 5 days per week, for 16 consecutive weeks. Neurobehavioral indices including gait score, hindlimb grip strength, and hindlimb landing foot splay were recorded periodically. Hematological and biochemical parameters were also measured during and after 1-BP exposure.The gait scores were significantly higher in the high-dose group (after 8 ∼ 16 weeks of 1-BP exposure), medium-dose group (after 14 ∼ 16 weeks of 1-BP exposure), and low-dose group (after 15 ∼ 16 weeks of 1-BP exposure) than in the control group (P < 0.05, P < 0.01). Compared with the control group, the high-dose group showed significantly decreased hindlimb grip strength after 9, 12, and 14 weeks of 1-BP exposure (P < 0.05, P < 0.01), with the hindlimbs paralyzed after 16 weeks of 1-BP exposure. After 16 weeks of 1-BP exposure, the hindlimb grip strengths of rats in the medium-dose and low-dose groups were decreased to 72.6% and 91.2% of the control value (P < 0.01, P < 0.05). Compared with the control group, the high-dose group showed significantly increased hindlimb landing foot splay after 12, 14, and 16 weeks of 1-BP exposure, and the medium-dose group showed significantly increased hindlimb landing foot splay after 14 and 16 weeks of 1-BP exposure (P < 0.05, P < 0.01). The high-dose and medium-dose groups showed significantly higher serum alanine aminotransferase (ALT) activity than the control group after 8 weeks of 1-BP exposure, and so did the low-dose group after 16 weeks of 1-BP exposure (P < 0.01).The nervous system is sensitive to the toxic effect of 1-BP, and 1-BP exposure can induce peripheral neuropathy in rats." @default.
• W308721738 created "2016-06-24" @default.
• W308721738 creator A5016123511 @default.
• W308721738 creator A5026241832 @default.
• W308721738 creator A5071316360 @default.
• W308721738 creator A5084978681 @default.
• W308721738 creator A5087034276 @default.
• W308721738 date "2012-10-01" @default.
• W308721738 modified "2023-09-23" @default.
• W308721738 title "[Development of peripheral neuropathy rat model induced by 1-bromopropane]." @default.
• W308721738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23257000" @default.
• W308721738 hasPublicationYear "2012" @default.
• W308721738 type Work @default.
• W308721738 sameAs 308721738 @default.
• W308721738 citedByCount "1" @default.
• W308721738 countsByYear W3087217382016 @default.
• W308721738 crossrefType "journal-article" @default.
• W308721738 hasAuthorship W308721738A5016123511 @default.
• W308721738 hasAuthorship W308721738A5026241832 @default.
• W308721738 hasAuthorship W308721738A5071316360 @default.
• W308721738 hasAuthorship W308721738A5084978681 @default.
• W308721738 hasAuthorship W308721738A5087034276 @default.
• W308721738 hasConcept C126322002 @default.
• W308721738 hasConcept C134018914 @default.
• W308721738 hasConcept C141071460 @default.
• W308721738 hasConcept C2777056448 @default.
• W308721738 hasConcept C2777433710 @default.
• W308721738 hasConcept C2778206080 @default.
• W308721738 hasConcept C2779491297 @default.
• W308721738 hasConcept C2779901536 @default.
• W308721738 hasConcept C29730261 @default.
• W308721738 hasConcept C42219234 @default.
• W308721738 hasConcept C46762472 @default.
• W308721738 hasConcept C51738704 @default.
• W308721738 hasConcept C555293320 @default.
• W308721738 hasConcept C71924100 @default.
• W308721738 hasConcept C79410662 @default.
• W308721738 hasConceptScore W308721738C126322002 @default.
• W308721738 hasConceptScore W308721738C134018914 @default.
• W308721738 hasConceptScore W308721738C141071460 @default.
• W308721738 hasConceptScore W308721738C2777056448 @default.
• W308721738 hasConceptScore W308721738C2777433710 @default.
• W308721738 hasConceptScore W308721738C2778206080 @default.
• W308721738 hasConceptScore W308721738C2779491297 @default.
• W308721738 hasConceptScore W308721738C2779901536 @default.
• W308721738 hasConceptScore W308721738C29730261 @default.
• W308721738 hasConceptScore W308721738C42219234 @default.
• W308721738 hasConceptScore W308721738C46762472 @default.
• W308721738 hasConceptScore W308721738C51738704 @default.
• W308721738 hasConceptScore W308721738C555293320 @default.
• W308721738 hasConceptScore W308721738C71924100 @default.
• W308721738 hasConceptScore W308721738C79410662 @default.
• W308721738 hasIssue "10" @default.
• W308721738 hasLocation W3087217381 @default.
• W308721738 hasOpenAccess W308721738 @default.
• W308721738 hasPrimaryLocation W3087217381 @default.
• W308721738 hasRelatedWork W2031656504 @default.
• W308721738 hasRelatedWork W2048773353 @default.
• W308721738 hasRelatedWork W2077375481 @default.
• W308721738 hasRelatedWork W2080015350 @default.
• W308721738 hasRelatedWork W2369042507 @default.
• W308721738 hasRelatedWork W2387573244 @default.
• W308721738 hasRelatedWork W2393563772 @default.
• W308721738 hasRelatedWork W2394330061 @default.
• W308721738 hasRelatedWork W308721738 @default.
• W308721738 hasRelatedWork W61837594 @default.
• W308721738 hasVolume "30" @default.
• W308721738 isParatext "false" @default.
• W308721738 isRetracted "false" @default.
• W308721738 magId "308721738" @default.
• W308721738 workType "article" @default.